Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas

NCT03687294 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03687294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03687294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas
Lead sponsor
Cairo University
Phase
Observational
Overall status
Unknown status
Start date
January 12, 2019
Completion date
December 31, 2021
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign neoplasm of salivary gland, malignant neoplasm of salivary gland